[1] [1] BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.

[7] [7] KURIHARA M, SEGI M. Cancer mortality for selected sites in 24 countries[M]. Sendai: Tohoku University School of Medicine, 1960.

[8] [8] KIM H J, FAY M P, FEUER E J, et al. Permutation tests for Joinpoint regression with applications to cancer rates[J]. Stat Med, 2000, 19(3): 335-351.

[9] [9] GONG Y M, PENG P, BAO P P, et al. The implementation and first-round results of a community-based colorectal cancer screening program in Shanghai, China[J]. Oncologist, 2018, 23(8): 928-935.

[17] [17] KNUDSEN A B, ZAUBER A G, RUTTER C M, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force[J]. JAMA, 2016, 315(23): 2595-2609.

[18] [18] CARDOSO R, GUO F, HEISSER T, et al. Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study[J]. Lancet Gastroenterol Hepatol, 2022, 7(8): 711-723.

[19] [19] DASGUPTA P, CAMERON J K, GOODWIN B, et al. Geographical and spatial variations in bowel cancer screening participation, Australia, 2015-2020[J]. PLoS One, 2023, 18(7): e0288992.

[20] [20] JIN P, WU Z T, LI S R, et al. Colorectal cancer screening with fecal occult blood test: a 22-year cohort study[J]. Oncol Lett, 2013, 6(2): 576-582.

[21] [21] CARDOSO R, GUO F, HEISSER T, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study[J]. Lancet Oncol, 2021, 22(7): 1002-1013.

[23] [23] KLIMKIEWICZ P. USPSTF colorectal cancer screening update 2021: a review of evidence[J]. Nurse Pract, 2022, 47(12): 37-42.

[24] [24] Australian Institute of Health and Welfare, HEALTH A G D O. Analysis of colorectal cancer outcomes for the Australian national bowel cancer screening program[J]. Asia Pac J Clin Oncol, 2016, 12(1): 22-32.

[25] [25] PARENTE F, VAILATI C, BOEMO C, et al. Improved 5-year survival of patients with immunochemical faecal blood testscreen-detected colorectal cancer versus non-screening cancers in northern Italy[J]. Dig Liver Dis, 2015, 47(1): 68-72.